Literature DB >> 3111359

Serum bactericidal rate as measure of antibiotic interactions.

L L Briceland, M T Pasko, J M Mylotte.   

Abstract

The serum bactericidal rate (SBR) assay was used to assess the antipseudomonal activity of gentamicin with or without piperacillin. Heat-inactivated donor serum was spiked with gentamicin, piperacillin, or a combination at concentrations representative of levels in serum and tested against five P. aeruginosa strains isolated from blood. The SBR assay was performed as follows: colony counts in test samples (control, gentamicin, piperacillin, and combination) were determined at 0, 2, 4, 6, and 8 h after inoculation of a test strain. Log10 CFU per milliliter was plotted versus time, and linear regression analysis was performed; the slope of the regression line was defined as the SBR. The SBRs of agents alone and in combination were compared statistically. The SBR of gentamicin was dependent on the serum concentration. The combination of gentamicin and piperacillin always resulted in a higher SBR than did either drug alone. However, this difference was not statistically significant for highly gentamicin-susceptible strains (MIC, less than or equal to 2 micrograms/ml) until the gentamicin concentration was reduced below the MIC. For a gentamicin-resistant strain (MIC, 8 micrograms/ml), the combination of gentamicin and piperacillin produced mean SBRs similar to that found with gentamicin-susceptible strains. These results provide evidence that the SBR assay may be a useful method of evaluating antibiotic interactions, since it can be done by using serum and since it compares the antibacterial activity of drugs statistically rather than requiring arbitrary criteria to define interactions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3111359      PMCID: PMC174814          DOI: 10.1128/AAC.31.5.679

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Serum bactericidal activity and killing rate for volunteers receiving imipenem, imipenem plus amikacin, and ceftazidime plus amikacin against Pseudomonas aeruginosa.

Authors:  P Van der Auwera; J Klastersky; H Lagast; M Husson
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

2.  Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin.

Authors:  P Van der Auwera; J Klastersky; S Lieppe; M Husson; D Lauzon; A P Lopez
Journal:  Antimicrob Agents Chemother       Date:  1986-02       Impact factor: 5.191

3.  In-vivo assessment of in-vitro killing patterns of Pseudomonas aeruginosa.

Authors:  A U Gerber; C Feller-Segessenmann
Journal:  J Antimicrob Chemother       Date:  1985-01       Impact factor: 5.790

4.  Value of serum tests in combined drug therapy of endocarditis.

Authors:  T A Drake; C J Hackbarth; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-11       Impact factor: 5.191

Review 5.  Antibiotic synergism and antimicrobial combinations in clinical infections.

Authors:  G M Eliopoulos; R C Moellering
Journal:  Rev Infect Dis       Date:  1982 Mar-Apr

6.  MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques.

Authors:  C J Shanholtzer; L R Peterson; M L Mohn; J A Moody; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

7.  Inoculum effect of new beta-lactam antibiotics on Pseudomonas aeruginosa.

Authors:  R H Eng; S M Smith; C Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

8.  Bactericidal effects of cefotetan and other antibiotics in human fluids.

Authors:  R W Lacey; V L Lord; G L Howson
Journal:  J Antimicrob Chemother       Date:  1983-01       Impact factor: 5.790

Review 9.  The aminoglycosides.

Authors:  A M Ristuccia; B A Cunha
Journal:  Med Clin North Am       Date:  1982-01       Impact factor: 5.456

10.  BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteers.

Authors:  A Pascual-Lopez; P Van der Auwera; S Lieppe; J Klastersky
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

View more
  9 in total

Review 1.  Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization.

Authors:  M A Pfaller; D J Sheehan; J H Rex
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

Review 2.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

3.  Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined.

Authors:  P Weber; Y Boussougant; R Farinotti; C Carbon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-06       Impact factor: 3.267

4.  The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions.

Authors:  R C Li; J J Schentag; D E Nix
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

Review 5.  Considerations in dosage selection for third generation cephalosporins.

Authors:  J H Yuk-Choi; C H Nightingale; T W Williams
Journal:  Clin Pharmacokinet       Date:  1992-02       Impact factor: 6.447

6.  Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin.

Authors:  P Van der Auwera
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

7.  Antipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curve.

Authors:  J E Tisdale; M T Pasko; J M Mylotte
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

Review 8.  Pulse dosing versus continuous infusion of antibiotics. Pharmacokinetic-pharmacodynamic considerations.

Authors:  M LeBel; M Spino
Journal:  Clin Pharmacokinet       Date:  1988-02       Impact factor: 6.447

Review 9.  Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance.

Authors:  L R Peterson; C J Shanholtzer
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.